Current challenges in the development of vaccines for pneumonic plague

Expert Rev Vaccines. 2008 Mar;7(2):209-21. doi: 10.1586/14760584.7.2.209.

Abstract

Inhalation of Yersinia pestis bacilli causes pneumonic plague, a rapidly progressing and exceptionally virulent disease. Extensively antibiotic-resistant Y. pestis strains exist and we currently lack a safe and effective pneumonic plague vaccine. These facts raise concern that Y. pestis may be exploited as a bioweapon. Here, I review the history and status of plague vaccine research and advocate that pneumonic plague vaccines should strive to prime both humoral and cellular immunity.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Antibodies, Bacterial / blood
  • Biological Warfare / prevention & control
  • Biomedical Research
  • Humans
  • Immunity, Cellular
  • Plague Vaccine* / administration & dosage
  • Plague Vaccine* / adverse effects
  • Plague Vaccine* / immunology
  • Plague Vaccine* / therapeutic use
  • Plague* / immunology
  • Plague* / prevention & control
  • Vaccines, Attenuated / administration & dosage
  • Vaccines, Attenuated / adverse effects
  • Vaccines, Attenuated / immunology
  • Vaccines, Attenuated / therapeutic use
  • Yersinia pestis / immunology
  • Yersinia pestis / pathogenicity

Substances

  • Antibodies, Bacterial
  • Plague Vaccine
  • Vaccines, Attenuated